Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
NCT00135200
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Iodine I 131 Tositumomab
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
[object Object]